Form 4: Elanco CFO Acquires Deferred Stock Units

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 8.1121 deferred stock units under a pre-arranged plan.

Summary

• Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc. (ELAN), acquired 8.1121 deferred stock units.
• The transaction occurred on January 9, 2026, at a price of $23.47 per unit.
• Each deferred stock unit represents the right to receive one share of the company's common stock or its cash equivalent.
• These units will settle in cash or shares following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.
• The acquisition was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.

Sentiment

Score: 6

Explanation: The acquisition of deferred stock units by a key executive is generally a neutral to slightly positive signal, indicating continued alignment of executive interests with shareholder value, especially when part of a pre-arranged plan. The small number of units acquired limits the overall impact on sentiment.

Positives

• The acquisition of deferred stock units by a key executive (CFO) can signal confidence in the company's future performance and aligns executive interests with shareholder value.
• The transaction was executed under a Rule 10b5-1(c) plan, which demonstrates a pre-arranged, non-discretionary acquisition strategy for compliance purposes.

Future Outlook

Deferred stock units are structured to settle in cash or shares of company common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan. This indicates a long-term incentive and retention mechanism for the executive.

Industry Context

This is a routine insider transaction report, reflecting executive compensation practices within the animal health industry. It does not provide specific insights into broader industry trends or competitive landscape beyond the company's internal compensation structure.

Comparison to Industry Standards

• The use of deferred stock units as part of executive compensation is a common practice across various industries, including the animal health sector, aligning executive incentives with long-term shareholder value.
• The execution of such transactions under a Rule 10b5-1(c) plan is standard for public company executives to manage insider trading compliance.

Corporate Governance

Related Party Transactions

• The acquisition of deferred stock units by Robert M. VanHimbergen, an executive officer, from Elanco Animal Health Inc. constitutes a related-party transaction as part of his compensation package.

Stakeholder Impact

• Shareholders: The acquisition of stock units by the CFO aligns executive interests with shareholder value, potentially signaling confidence in the company's long-term prospects.
• Employees: This transaction reflects the company's executive compensation structure and long-term incentive programs.

Next Steps

• The deferred stock units will settle in cash or shares of company common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 reports a routine, small acquisition of deferred stock units by a key executive as part of a compensation plan. While it shows executive alignment, the transaction size is too small to warrant a change in investment recommendation based solely on this filing. It does not provide new fundamental information about the company's operational performance or strategic direction.

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Trading, Deferred Stock Units, Executive Compensation, Robert M. VanHimbergen, CFO, Stock Acquisition, Rule 10b5-1